Logo

Flagship Biosciences: Tom Turi

Sep 28, 2022

Flagship Biosciences has appointed Tom Turi as its new chief scientific officer. Prior to joining Flagship, Turi had served as CSO at Nexelis, VP of companion diagnostics for Labcorp Drug Development, and in several positions at Pfizer. Turi holds a bachelor's degree in biochemistry and chemistry from University of Illinois Urbana-Champaign and a PhD in molecular genetics from University of Cincinnati College of Medicine.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.